Upgrading Category III Antiperspirants to Category I (43 FR 46728-46731)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 1, 1978
May 6, 2020
184d6022-1c6c-47e6-a19a-3d6c3c52a58d
Related Documents
Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application
Guidance DocumentFebruary 1, 1987Center for Drug Evaluation and Research
Study of Drugs Likely to be used in the Elderly
Guidance DocumentNovember 1, 1989Center for Drug Evaluation and Research
Preparation of Investigational New Drug Products (Human and Animal): Guidance for Industry
Guidance DocumentNovember 1, 1992Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.